| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 21, 2001
Accepted on February 13, 2002
Gene
Polymorphisms With Coronary Artery Disease in Patients With Familial
Hypercholesterolemia
From Molecular Genetics of Cardiovascular Disorders, Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
* To whom correspondence should be addressed. E-mail: hgshkt{at}im2.m.kanazawa-u.ac.jp.
AbstractTo
investigate the association of estrogen receptor (ER)-
gene
polymorphisms with coronary artery disease (CAD), we
studied 197 men and 98 postmenopausal women with heterozygous familial
hypercholesterolemia. We examined the known
polymorphisms, including PvuII,
XbaI, TA repeat, and CA repeat,
and identified 6 novel polymorphisms in the ER-
gene. The
distributions of -1989T/G (a novel polymorphism in promoter B)
and XbaI in intron 1 were
associated with CAD in postmenopausal women and in men, with a higher
frequency of the G/G genotype
(P=0.03) or X1/X1
genotype (P=0.02) in
the CAD group. The frequency of alleles of TA repeats >17 was
found to be significantly higher in postmenopausal women with CAD than
in those without CAD (P=0.04),
but not in men. Logistic regression analysis with all
coronary risk factors as covariates showed that the G/G
genotype was a higher risk for CAD (odds ratio 4.5, 95% CI 1.0
to 19.5; P=0.04) but that X1/X1
was not. We conclude that -1989T/G or its linked polymorphisms in
the ER-
gene may confer risk for CAD and that the G/G
genotype may be an independent predictor for CAD in patients
with familial hypercholesterolemia.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |